Cosmeceuticals—cosmetic products that deliver pharmaceutical-like benefits—are a rapidly growing sector of the cosmetic and anti-aging industry. Among the most exciting innovations are exosomes, small extracellular vesicles that transport bioactive substances such as proteins, lipids, and nucleic acids to target cells, influencing gene expression and cellular behavior. Their ability to promote collagen production, tissue regeneration, and anti-inflammatory effects has positioned them as powerful tools in skincare and cosmetic applications. [Read more…]
RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing
FREDERICK, MD., (April 29, 2025) —RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the potential to revolutionize the treatment of degenerative disease. [Read more…]
Designer Exosomes: The Future of Targeted Therapy and Regenerative Medicine
In the evolving landscape of biomedical innovation, exosomes have emerged as one of the most promising tools for next-generation therapies. These nanoscale, membrane-bound vesicles, naturally secreted by cells, play a critical role in intercellular communication. Because of their inherent ability to shuttle biomolecules like RNA, proteins, and lipids between cells, exosomes have captivated the attention of researchers and biotech companies for their vast potential in therapeutic applications. [Read more…]
Exosome Research: Who Is Dominating in the Scientific Literature?
Exosome research is experiencing rapid growth, driven by the increasing recognition of their critical role in intercellular communication and molecular transport. These extracellular vesicles act as natural carriers of proteins, lipids, and genetic material, influencing a wide range of physiological and pathological processes. As a result, they are emerging as a promising tool in regenerative medicine, drug delivery, and disease diagnostics.
Beyond their biological significance, exosomes are attracting attention for their potential therapeutic applications. Because they can mediate many of the beneficial effects traditionally associated with cells—without the same risks of immune rejection or uncontrolled proliferation—they are increasingly attracting attention and investment. [Read more…]
Dr. Askenase on the Role of MSC-Derived Exosomes in Healing the Injured Spinal Cord
This interview features Dr. Philip Askenase, MD, a Professor of Medicine and Pathology at Yale University School of Medicine. A leading expert in the effector properties of exosomes, Dr. Askenase is now delving into the regenerative potential of mesenchymal stem cell (MSC)-derived exosomes.
His latest, as-yet-unpublished research focuses on using MSC-derived exosomes to promote healing in injured spinal cords in rats. In our conversation, we examine the expanding significance of MSC-derived exosomes, their unique advantages, and diverse applications. We also discuss the market opportunities for stem cell exosomes and the companies driving innovation in this emerging field.
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 27
- Next Page »